Abstract:The epithelial components of the breast are thought to arise from a stem cell population that is capable of both self-renewal and lineage-specific differentiation. We and others have hypothesized that mammary stem cells or their immediate progeny are targets for transformation during carcinogenesis. Normal stem cells and carcinoma cells share many characteristics including self-renewal capacity, telomerase expression, ability to differentiate, resistance to apoptosis, and ability to home to specific sites. Mammary transformation may require dysregulation of pathways that control normal stem cell self-renewal such as Notch, Wnt, Hedgehog, and Bmi-1. In order to study these pathways in normal mammary development, we have developed an in vitro culture system in which primary human epithelial cells isolated from reduction mammoplasties are cultured as 'mammospheres' on non-adherent surfaces. Cells within mammospheres are able to self-renew, as well as to differentiate into all the lineages found in the mammary gland. Utilizing this system, we demonstrate bidirectional interaction between Notch and Hedgehog signaling and Bmi-1 in the regulation of stem cell self-renewal. When mammospheres are admixed with irradiated human mammary fibroblasts and implanted into the cleared fatpads of NOD/SCID mice, they are able to reconstitute the ductal alveolar structures found in the human mammary gland. The stem cell model of carcinogenesis may also provide a partial explanation for the generation of cellular heterogeneity seen within mammary tumors. Using flow cytometry, we have identified a small population of cells within primary or metastatic breast cancers that bear the cell surface phenotype ESA+CD44+CD24-/lowLineage- that have the properties of human tumor stem cells. As few as 200 of these cells are able to reproducibly generate tumors in NOD/SCID mice, while the vast majority of cells in these tumors that lack this phenotype are incapable of tumor formation even when tens of thousands of cells are injected. Consistent with a stem cell model, tumorigenic cells generate tumors that recapitulate the phenotypic heterogeneity found in the original tumors. We have demonstrated that pathways that control normal stem cell self-renewal, such as Hedgehog, are activated in mammary tumor stem cells, compared with their differentiated progeny. Despite progress in breast cancer therapeutics, metastatic breast cancer remains an incurable disease. Current therapies that have been developed by virtue of their ability to induce tumor regression may selectively target more differentiated cells in tumors, while leaving the tumor stem cell population intact, accounting for treatment resistance and relapse. Multiple mechanisms may account for this resistance to apoptosis, including increased expression of anti-apoptotic genes, increased DNA repair mechanisms, and transporter proteins such as BCRP found in the tumor stem cell population. The targeting of stem cell self-renewal pathways such as Hedgehog or Notch may thus provide a novel and more effective approach for the treatment of advanced breast cancer.

Stem Cell Division and Its Critical Role in Mammary Gland Development and Tumorigenesis: Current Progress and Remaining Challenges

Stem Cells and Cellular Origins of Breast Cancer: Updates in the Rationale, Controversies, and Therapeutic Implications

Stem Cells in Human Breast Development and Cancer

Role, Molecular Mechanism and the Potential Target of Breast Cancer Stem Cells in Breast Cancer Development

Stem Cells and Cellular Origins of Mammary Gland: Updates in Rationale, Controversies, and Cancer Relevance

Stem cells in mammary development and carcinogenesis

Asymmetric cell division of mammary stem cells

Symmetric and asymmetric cell division in mammalian development and the initiation and progression of tumor

Mammary gland stem cells and their application in breast cancer

Faculty Opinions recommendation of The tumor suppressor p53 regulates polarity of self-renewing divisions in mammary stem cells.

Breast Cancer Stem Cells: Biomarkers, Identification and Isolation Methods, Regulating Mechanisms, Cellular Origin, and Beyond

Advances in Biomarkers and Endogenous Regulation of Breast Cancer Stem Cells.

Breast cancer stem cells: current advances and clinical implications.

Mammary Stem Cells: Angels or Demons in Mammary Gland?

MicroRNA regulation of cancer stem cells in the pathogenesis of breast cancer

Some recent progress on breast cancer stem cells

Research progress in breast cancer stem cells: characterization and future perspectives

Progress on breast cancer stem cells as a new target for the studies and treatment of breast cancer

Role of cancer stem cell ecosystem on breast cancer metastasis and related mouse models

13 Breast Cancer Stem Cells

Identification and Characterization of Cancer Initiating Cells from BRCA1 Related Mammary Tumors Using Markers for Normal Mammary Stem Cells